These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 22710723)
1. Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14. Zhang P; Guo A; Possemato A; Wang C; Beard L; Carlin C; Markowitz SD; Polakiewicz RD; Wang Z Oncogene; 2013 Apr; 32(16):2087-95. PubMed ID: 22710723 [TBL] [Abstract][Full Text] [Related]
2. Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T. Zhao Y; Zhang X; Guda K; Lawrence E; Sun Q; Watanabe T; Iwakura Y; Asano M; Wei L; Yang Z; Zheng W; Dawson D; Willis J; Markowitz SD; Satake M; Wang Z Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2592-7. PubMed ID: 20133777 [TBL] [Abstract][Full Text] [Related]
3. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab. Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL Oncogene; 2011 Feb; 30(5):561-74. PubMed ID: 20956938 [TBL] [Abstract][Full Text] [Related]
4. Regulation of paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts colon tumorigenesis. Zhao Y; Scott A; Zhang P; Hao Y; Feng X; Somasundaram S; Khalil AM; Willis J; Wang Z Oncotarget; 2017 Jul; 8(30):48782-48793. PubMed ID: 27447856 [TBL] [Abstract][Full Text] [Related]
5. Global phosphotyrosine proteomics identifies PKCδ as a marker of responsiveness to Src inhibition in colorectal cancer. McKinley ET; Liu H; McDonald WH; Luo W; Zhao P; Coffey RJ; Hanks SK; Manning HC PLoS One; 2013; 8(11):e80207. PubMed ID: 24260357 [TBL] [Abstract][Full Text] [Related]
7. CSRP2 suppresses colorectal cancer progression Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270 [TBL] [Abstract][Full Text] [Related]
8. p130Cas Is Correlated with EREG Expression and a Prognostic Factor Depending on Colorectal Cancer Stage and Localization Reducing FOLFIRI Efficacy. Kumbrink J; Li P; Pók-Udvari A; Klauschen F; Kirchner T; Jung A Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830244 [TBL] [Abstract][Full Text] [Related]
9. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Nam S; Kim D; Cheng JQ; Zhang S; Lee JH; Buettner R; Mirosevich J; Lee FY; Jove R Cancer Res; 2005 Oct; 65(20):9185-9. PubMed ID: 16230377 [TBL] [Abstract][Full Text] [Related]
10. p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. Ambrogio C; Voena C; Manazza AD; Piva R; Riera L; Barberis L; Costa C; Tarone G; Defilippi P; Hirsch E; Boeri Erba E; Mohammed S; Jensen ON; Palestro G; Inghirami G; Chiarle R Blood; 2005 Dec; 106(12):3907-16. PubMed ID: 16105984 [TBL] [Abstract][Full Text] [Related]
14. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Johnson FM; Saigal B; Talpaz M; Donato NJ Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784 [TBL] [Abstract][Full Text] [Related]
15. The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. Baker AM; Cox TR; Bird D; Lang G; Murray GI; Sun XF; Southall SM; Wilson JR; Erler JT J Natl Cancer Inst; 2011 Mar; 103(5):407-24. PubMed ID: 21282564 [TBL] [Abstract][Full Text] [Related]
16. Nonreceptor tyrosine phosphatase 14 promotes proliferation and migration through regulating phosphorylation of YAP of Hippo signaling pathway in gastric cancer cells. Han X; Sun T; Hong J; Wei R; Dong Y; Huang D; Chen J; Ren X; Zhou H; Tian W; Jia Y J Cell Biochem; 2019 Oct; 120(10):17723-17730. PubMed ID: 31168824 [TBL] [Abstract][Full Text] [Related]
17. P130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated protein involved in cell spreading. Di Stefano P; Cabodi S; Boeri Erba E; Margaria V; Bergatto E; Giuffrida MG; Silengo L; Tarone G; Turco E; Defilippi P Mol Biol Cell; 2004 Feb; 15(2):787-800. PubMed ID: 14657239 [TBL] [Abstract][Full Text] [Related]
18. Focal adhesion targeting of v-Crk is essential for FAK phosphorylation and cell migration in mouse embryo fibroblasts deficient src family kinases or p130CAS. Yeo MG; Sung BH; Oh HJ; Park ZY; Marcantonio EE; Song WK J Cell Physiol; 2008 Mar; 214(3):604-13. PubMed ID: 17786957 [TBL] [Abstract][Full Text] [Related]
19. Tyrosine Y189 in the substrate domain of the adhesion docking protein NEDD9 is conserved with p130Cas Y253 and regulates NEDD9-mediated migration and focal adhesion dynamics. Baquiran JB; Bradbury P; O'Neill GM PLoS One; 2013; 8(7):e69304. PubMed ID: 23874939 [TBL] [Abstract][Full Text] [Related]
20. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. Sakai R; Iwamatsu A; Hirano N; Ogawa S; Tanaka T; Mano H; Yazaki Y; Hirai H EMBO J; 1994 Aug; 13(16):3748-56. PubMed ID: 8070403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]